The plaintiffs in a class-action lawsuit had asked for an injunction after two men with serious medical needs died in ...

Immunocore announces 2026 strategic priorities at 44 th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

PlusAI, a leader in AI software for autonomous trucks, today provided an update on its commercial readiness metrics, demonstrating continued momentum across safety validation and operational ...

The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...

Julie Young is an experienced financial writer and editor. She specializes in financial analysis in capital planning and investment management. Thomas J. Brock is a CFA and CPA with more than 20 years ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...

Yesterday, I posted the account of a WHO summit on so-called alternative medicine (SCAM). I deliberately abstained from any comment. Yet, the arguments put forward do certainly deserve some critical ...